Your browser doesn't support javascript.
loading
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation.
Torres-Guzmán, Raquel; Ganado, Maria Patricia; Mur, Cecilia; Marugan, Carlos; Baquero, Carmen; Yang, Yanzhu; Zeng, Yi; Bian, Huimin; Du, Jian; de Dios, Alfonso; Puig, Oscar; Lallena, María José.
Afiliação
  • Torres-Guzmán R; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
  • Ganado MP; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
  • Mur C; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
  • Marugan C; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
  • Baquero C; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
  • Yang Y; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Zeng Y; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Bian H; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Du J; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • de Dios A; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Puig O; Eli Lilly and Company, New York, NY 10016, USA.
  • Lallena MJ; Discovery Chemistry Research and Technology, Eli Lilly and Company, Madrid, Spain.
Oncotarget ; 13: 864-875, 2022.
Article em En | MEDLINE | ID: mdl-35813283
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha